Analyst Ratings for Amylin Pharmaceuticals (AMLN)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 2.3 / 10 Percentile Rank: 15%
Rating Score: 2.3 / 10 Percentile Rank: 15%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
7/3/2012 | Morgan Stanley | N/A | Upgrade | Equalweight (Underweight) |
N/A (N/A) |
30.71 (30.98) |
0.88% | Details |
7/2/2012 | BMO Capital | N/A | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
28.20 (30.98) |
9.86% | Details |